At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 6, 2026 at 09:45 ET
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 25,286,624 shares of Tango Therapeutics common stock as of October 30, 2026, representing 15.0% of shares outstanding. This is an increase from the prior filing, which did not specify a stake percentage but listed Fidelity Management & Research Company LLC as a 5%+ owner. The filing is a routine passive stake update with no change in investment intent.
- FMR LLC reported beneficial ownership of 25,286,624 shares of Tango Therapeutics common stock as of October 30, 2026.
- The stake represents 15.0% of the outstanding shares.
- Fidelity Management & Research Company LLC is the entity within FMR that owns 5% or greater of the shares.
- The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access